Assignee
JUNCTUCELL BIOMED MFG GMBH
DE·1 granted patent·3 pending applications·2 citations·filing 2020–2023
Top patents by PatentIndex Score
4 records- 0175US11464806B2Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cellsJUNCTUCELL BIOMED MFG GMBH·Filed 2020·Granted Oct 11, 2022·2 cites·20 claims
- 0264US2023226222A1Genetically modified mesenchymal stem cells expressing alpha-1 antitrypsin (aat)JUNCTUCELL BIOMED MFG GMBH·Filed 2023·Application pending·0 cites
- 0356US2023063829A1Mesenchymal stem cells to enhance anti-tumor activity of immunotherapyJUNCTUCELL BIOMED MFG GMBH·Filed 2022·Application pending·0 cites
- 0449US2020289577A1Protection of the vascular endothelium from immunologically mediated cytotoxic reactions with human cd34-negative progenitor cellsJUNCTUCELL BIOMED MFG GMBH·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when JUNCTUCELL BIOMED MFG GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →